Weight changes in Alzheimer's disease patients with increased aberrant motor behavior

International Journal of Geriatric Psychiatry

Volumn 28, Issue 10, 2013, Pages 998-1004

  Secher, Marion ^a,b   Andrieu, Sandrine ^a,b,c,d   Gillette Guyonnet, Sophie ^a,b,c   Soto, Maria ^a,b,c   Rolland, Yves ^a,b,c   Cantet, Christelle ^a,b,c   Vellas, Bruno ^a,b,c   Ritz, Patrick ^a,b,c,d  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b Gerontopole   (France)

^c INSERM   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

aberrant motor behavior; Alzheimer's disease; body weight changes; wandering

Indexed keywords

CHOLINESTERASE INHIBITOR; PSYCHOTROPIC AGENT;

ABERRANT MOTOR BEHAVIOR; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROPSYCHIATRIC INVENTORY SCALE; RATING SCALE; WEIGHT CHANGE; WEIGHT REDUCTION;

ABERRANT MOTOR BEHAVIOR; ALZHEIMER'S DISEASE; BODY WEIGHT CHANGES; WANDERING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BODY WEIGHT; EMOTIONS; FEMALE; HUMANS; MALE; MOTOR ACTIVITY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; WEIGHT GAIN;

EID: 84883557043     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3914     Document Type: Article

References (34)

1. Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FRJ, 2005. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry 20: 523-530. (Pubitemid 40873344)
2. Andrieu S, Reynish W, Nourhashemi F, et al,. 2001. Nutritional risk factors for institutional placement in Alzheimer's disease after one-year follow-up. J Nutr Health Aging 5: 113-117. (Pubitemid 32539597)
3. Coley N, Gardette V, Toulza O, et al,. 2008. Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study. Neuroepidemiology 31: 69-79.
4. Cummings JL, Mega M, Gray K, et al,. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314. (Pubitemid 24382728)
5. Du W, DiLuca C, Growdon JH,. 1993. Weight loss in Alzheimer's disease. J Geriatr Psychiatry Neurol 6: 34-38. (Pubitemid 23050679)
6. Folstein MF, Folstein SE, McHugh PR,. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
7. Gillette Guyonnet S, Abellan Van Kan G, Alix E, et al,. 2007. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging 11: 38-48. (Pubitemid 46424268)
8. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al,. 2003. The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. J Nutr Health Aging 7, 91-96. (Pubitemid 36506207)
9. Guérin O, Andrieu S, Schneider SM, et al,. 2005. Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients. Am J Clin Nutr 82: 435-441.
10. Guigoz Y,. 2006. The Mini Nutritional Assessment (MNA) review of the literature-what does it tell us? J Nutr Health Aging 10: 466-485; discussion 485-487. (Pubitemid 46127189)
11. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW,. 1963. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 185: 914-919.
12. Larson EB, Shadlen M-F, Wang L, et al,. 2004. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 140: 501-509.
13. Lawton MP, Brody EM,. 1969. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: 179-186.
14. Lyketsos CG, Lopez O, Jones B, et al,. 2002. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288: 1475-1483.
15. Margallo-Lana M, Swann A, O'Brien J, et al,. 2001. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry 16, 39-44. (Pubitemid 32111815)
16. Matsumoto N, Ikeda M, Fukuhara R, et al,. 2007. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord 23: 219-224. (Pubitemid 46496807)
17. McKhann G, Drachman D, Folstein M, et al,. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944. (Pubitemid 14076461)
18. Morris JC,. 1993. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412-2414. (Pubitemid 23346995)
19. Okura T, Plassman BL, Steffens DC, et al,. 2010. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc 58: 330-337.
20. Pramyothin P, Khaodhiar L,. 2010. Metabolic syndrome with the atypical antipsychotics. Curr Opin Endocrinol Diabetes Obes 17: 460-466.
21. Reynish E, Cortes F, Andrieu S, et al,. 2007. The ICTUS Study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 29: 29-38. (Pubitemid 350191415)
22. Rolland Y, Andrieu S, Cantet C, et al,. 2007. Wandering behavior and Alzheimer disease. The REAL.FR prospective study. Alzheimer Dis Assoc Disord 21: 31-38. (Pubitemid 46398953)
23. Rosen WG, Mohs RC, Davis KL,. 1984. A new rating scale for Alzheimer's disease. Am J Psychiatry 141: 1356-1364.
24. Schneider LS, Tariot PN, Lyketsos CG, et al,. 2001. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry 9: 346-360. (Pubitemid 33015123)
25. Serretti A, Mandelli L,. 2010. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 71: 1259-1272.
26. Spaccavento S, Del Prete M, Craca A, Fiore P,. 2009. Influence of nutritional status on cognitive, functional and neuropsychiatric deficits in Alzheimer's disease. Arch Gerontol Geriatr 48: 356-360.
27. Steinberg M, Tschanz JT, Corcoran C, et al,. 2004. The persistence of neuropsychiatric symptoms in dementia: the Cache County study. Int J Geriatr Psychiatry 19: 19-26. (Pubitemid 38180688)
28. Steinberg M, Shao H, Zandi P, et al,. 2008. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County study. Int J Geriatr Psychiatry 23: 170-177. (Pubitemid 351308497)
29. Vellas B, Lauque S, Gillette-Guyonnet S, et al,. 2005. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 9: 75-80. (Pubitemid 40478062)
30. White H, Pieper C, Schmader K, Fillenbaum G,. 1996. Weight change in Alzheimer's disease. J Am Geriatr Soc 44: 265-272. (Pubitemid 26081092)
31. White H, Pieper C, Schmader K,. 1998. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc 46: 1223-1227. (Pubitemid 28467424)
32. White HK, McConnell ES, Bales CW, Kuchibhatla M,. 2004. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects. J Am Med Dir Assoc 5: 89-97. (Pubitemid 38380407)
33. Zarit SH, Reever KE, Bach-Peterson J,. 1980. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20: 649-655. (Pubitemid 11170845)
34. Zheng L, Mack WJ, Dagerman KS, et al,. 2009. Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry 166: 583-590.